Apontis Pharma Dividends and Buybacks

Dividend criteria checks 0/6

Apontis Pharma does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.6%

Buyback Yield

Total Shareholder Yield0.6%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We Think Apontis Pharma (ETR:APPH) Can Afford To Drive Business Growth

Oct 17
We Think Apontis Pharma (ETR:APPH) Can Afford To Drive Business Growth

Further Upside For Apontis Pharma AG (ETR:APPH) Shares Could Introduce Price Risks After 35% Bounce

Oct 17
Further Upside For Apontis Pharma AG (ETR:APPH) Shares Could Introduce Price Risks After 35% Bounce

Health Check: How Prudently Does Apontis Pharma (ETR:APPH) Use Debt?

Jun 18
Health Check: How Prudently Does Apontis Pharma (ETR:APPH) Use Debt?

Potential Upside For Apontis Pharma AG (ETR:APPH) Not Without Risk

Apr 05
Potential Upside For Apontis Pharma AG (ETR:APPH) Not Without Risk

We Think Apontis Pharma (ETR:APPH) Can Afford To Drive Business Growth

Dec 02
We Think Apontis Pharma (ETR:APPH) Can Afford To Drive Business Growth

Not Many Are Piling Into Apontis Pharma AG (ETR:APPH) Stock Yet As It Plummets 27%

Jul 29
Not Many Are Piling Into Apontis Pharma AG (ETR:APPH) Stock Yet As It Plummets 27%

Apontis Pharma's (ETR:APPH) Robust Earnings Are Supported By Other Strong Factors

Apr 08
Apontis Pharma's (ETR:APPH) Robust Earnings Are Supported By Other Strong Factors

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if APPH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if APPH's dividend payments have been increasing.


Dividend Yield vs Market

Apontis Pharma Dividend Yield vs Market
How does APPH dividend yield compare to the market?
SegmentDividend Yield
Company (APPH)n/a
Market Bottom 25% (DE)1.7%
Market Top 25% (DE)4.9%
Industry Average (Pharmaceuticals)1.4%
Analyst forecast (APPH) (up to 3 years)0%

Notable Dividend: Unable to evaluate APPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate APPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate APPH's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as APPH has not reported any payouts.


Discover strong dividend paying companies